CORONAVIRUS
LIVE UPDATES

Interview on the impact of
SARS-CoV-2 on dental implantology Saliva testing for SARS-CoV-2 takes offSARS-CoV-2 variant identified in South Africa complicates inoculation plansNHS dental activity targets continue to attract controversyPandemic-proof? Align Technology sold a record number of clear aligners in 2020Researchers stress importance of appropriate PPE selection during COVID-19 pandemicStudy links periodontitis and COVID-19 complicationsInterview: Scientists design SARS-CoV-2-removing vacuum helmetElective dental care suspended in DubaiOral care during pandemic: Report shows surge in sales of DIY dental kits

Visit microsite

ACTEON

ePaper

ePaper editions are exact digital copies of the DTI print publications. All publications that include information about ACTEON’s products can be found here.

digital international No. 4, 2020

digital international No. 3, 2020

roots international No. 3, 2020

digital international No. 2, 2020

implants international No. 2, 2020

digital international No. 1, 2020

cosmetic dentistry Turkey No. 2, 2019

roots Turkey No. 2, 2019

implants Poland No. 4, 2019

today ADF Paris Nov. 29, 2019

today ADF Paris Nov. 28, 2019

Zahnärztliche Assistenz No. 2, 2019

1 2 … 6 7 Older Posts

Everything ACTEON

17 avenue Gustave Eiffel, BP 30216
MERIGNAC cedex, 33708
France
Tel.: +33 (0) 556 34 06 07
Fax: +33 (0) 556 34 92 92

www.acteongroup.com
info@acteongroup.com

NewsView All

Piezotome extractions favour bone preservation with immediate implant placement

November 02, 2020 | Events, Interviews, News

BORDEAUX, France: Tooth extraction is the most common procedure performed in oral surgery.¹ For example, ten million third molars are removed each year in the US alone, according to the American Public Health Association.² Dentists are ethically committed to using the least traumatic surgical options and least invasive techniques in order to ensure patients’ well-being, thus less traumatic extraction and implant placement are becoming the norm in today’s implant surgery.

Michael Rynerson appointed CEO of ACTEON

June 22, 2020 | Events, Interviews, News

BORDEAUX, France: Michael Rynerson is the new CEO of the dental and medical technology and device manufacturer ACTEON, which is headquartered in France. The supervisory board of Finapolline, the holding company of ACTEON, appointed him to the position effective on 1 June. The chairman of the supervisory board commented that Rynerson has over 25 years of experience, most notably in the dental industry, and possesses the skills to lead the company out of the current health and economic crisis and through its next phase of development.

EXPASYL EXACT: Effective and atraumatic gingival retraction

February 21, 2020 | Events, Interviews, News

CHICAGO, U.S.: Few products have had such a positive effect on dentistry as the EXPASYL gingival retraction paste from ACTEON. After 20 years of clinical research and efficacy, EXPASYL continues to be the choice of many dentists for tissue management during restorative and cosmetic dental treatment. Now, EXPASYL EXACT is available on the market. It offers the same results in the exact amount needed in a cost-effective, single-use capsule that can be used in any composite gun. This means that there will be no more wasted material and there is no need to purchase expensive application guns. At the 155th Chicago Dental Society Midwinter Meeting currently being held in Chicago, interested parties can view the new product at the ACTEON booth (#2811).

WebinarsView All